You are here

Article info

Article menu
XML
Osteoarthritis
Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis

Authors

  1. Correspondence to Dr Joyce B van Meurs, Internal Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; j.vanmeurs{at}erasmusmc.nl
View Full Text

Citation

Boer CG, Szilagyi I, Nguyen NL, et al
Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis
Annals of the Rheumatic Diseases 2021;80:598-604.

Publication history

  • Received November 11, 2020
  • Revised January 19, 2021
  • Accepted January 20, 2021
  • First published April 12, 2021.
Online issue publication 
April 12, 2021

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Lay summary

    Disclaimer : This is a summary of a scientific article written by a medical professional (“the Original Article”). The Summary is written to assist non medically trained readers to understand general points of the Original Article. It is supplied “as is” without any warranty. You should note that the Original Article (and Summary) may not be fully relevant nor accurate as medical science is constantly changing and errors can occur. It is therefore very important that readers not rely on the content in the Summary and consult their medical professionals for all aspects of their health care and only rely on the Summary if directed to do so by their medical professional. Please view our full Website Terms and Conditions.
    Copyright © 2021 BMJ Publishing Group Ltd & European League Against Rheumatism. Medical professionals may print copies for their and their patients and students non commercial use. Other individuals may print a single copy for their personal, non commercial use. For other uses please contact our Rights and Licensing Team.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.